Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Jan MalaskaJan StašekFrantišek DuškaMartin BalíkJan MácaJan HrudaTomáš VymazalOlga KlementováJan ZatloukalTomáš GabrhelíkPavel NovotnýRegina DemlováJana KubátováJana VinklerováAdam SvobodníkMilan KratochvílJozef KlučkaRoman GálMervyn Singernull nullPublished in: Trials (2021)
The full protocol (version 1.1) is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest of expediting dissemination of this material, the standard formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.
Keyphrases
- study protocol
- randomized controlled trial
- open label
- phase iii
- phase ii
- clinical trial
- coronavirus disease
- sars cov
- acute respiratory distress syndrome
- low dose
- high dose
- mechanical ventilation
- psychometric properties
- squamous cell carcinoma
- radiation therapy
- intensive care unit
- placebo controlled
- double blind
- rectal cancer
- locally advanced